Aquestive Therapeutics, Inc. AQST Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s enterprise value?
- Aquestive Therapeutics, Inc. (AQST) reported enterprise value of $460.11M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s enterprise value changed year-over-year?
- Aquestive Therapeutics, Inc.'s enterprise value increased by 65.5% year-over-year, from $277.97M to $460.11M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s enterprise value has grown at a 31.2% compound annual growth rate (CAGR), from $186.64M to $726.59M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.